Ibritumomab tiuxetan
Product Specifications
CAS Number
206181-63-7
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9866
Bioactivity
Ibritumomab tiuxetan (IDEC-129) is an antibody targeting CD20, conjugated to a radioactive isotope via a chelating agent Tiuxetan, and can be used in radioimmunotherapy.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog